Attachment II - Page 2 
i 911O-0L2* (T) 
{ 9202-O13' (T) 
I 
! 9202-0U (M) 
I 
I 
9202-015 (M) 
i 
I 
I 
i 9202-016* (T) 
I 
I 9202-017*> (M) 
I 
i 
9206-018 (D 
9206^19 (T) 
9206-020* (M) 
I 92064)21 (T) 
92064)22* (T) 
I 
i 
92064)23* (M) 
9206-024* (M) 
Wilson, James University of Pennsylvania, Philadelphia, Pennsylvania^ Ex Vivo Gme Therapy of Familial HypercholesteroUmia. 
RAC Approval: 10-8-91/NIH Approval: 11-14-91 
Minor Modification: 12-3-92 
Minor Modification: 8-18-93 
Nabel, Gary J., University of Michigan, Ann Arbor, Michigan; Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors. 
RAC Approval: 2-10-92/NIH Approval: 4-17-92 
Minor Modification; 1-22-93 
Minor Modification; 1-93 
Cornetta, Kenneth, Indiana University, Indianapolis, Indiana; Retroviral-Mediated Gene Transfer of Bone Marrow Cells during 
Autologous Bone Marrow Transplantation for Acute Leukemia. 
RAC Approval: 2-11-92/NIH Approval: 4-17-92 
Economou, James S. and Belldegrun, Arie, University of California at Lxk Angeles, Los Angeles, California; The Treatment of 
Patients with Metastatic Melanoma and Renal Cell Cancer Using In Vitro Expanded and Genetically-Engineered (Neomycin 
Phosphotransferase) Bulk, CDS (+) and/or CD4(+) Tumor hyfiltradng Lymphocytes and Bulk, CDS(+) and/or CD4(+) Peripheral 
Blood Leukocytes in Combination with Recombinant Interleukin-2 Alone, or with Recombinant Interieukin-2 and Recombinant Alpha 
Interferon. 
RAC Approval; 2-11-92/NlH Approval: 4-17-92 
Freeman, Scott M., Tulane University Medical Center, New Orleans, Louisiana; Gene Transfer for the Treatment of Carxeer. 
RAC Approval: 2-16-92/NlH Approval: 2-5-93 
Minor Modification; 8-6-93 
Greenberg, Philip D. and Riddell, Stanley, Fred Hutchinson Cancer Research Center, University of Washington, Seattle; Phase I 
Study to Evaluate the Safety of Cellular Adoptive Immunotherapy using Genetically Modified CDS+ HIV-Specific T Cells in HIV 
Seropositive Individuals. 
RAC Approval; 2-11-92/NIH Approval; 4-17-92 
Major Amendment/RAC Approval: 9-9-93 
Major Amendment/NIH Approval: 10-7-93 
Brenner, Malcolm K.; Furman, Wayne; Santana, Victor, Bowman, Laura; and Meyer, William, St. Jude Children’s Research 
Hospital, Memphis, Tennessee; Phase I Study of CytoUne-Gene Modified Autologous Neuroblastoma Cells for Treatment of 
Relapsed/Refraciory Neuroblastoma. 
RAC Approval: 6-1-92/NIH Approval: 8-14-92 
Oldfield, Edward, National Institutes of Health, Bethesda, Maryland; Gene Therapy for the Treatment of Brain Tumors Using Intra- 
Tumoral Transduction with the Thymidine Kinase Gene and Intravertous Ganciclovir. 
RAC Approval: 6-1-92/NIH Approval: 8-14-92 
Minor Modification; 11-29-93 
Deisseroth, Albert B., MD Anderson Cancer Center, Houston, Texas; Use of Two Retroviral Markers to Test Relative Contribution of 
Marrow and Peripheral Blood Autologous Cells to Recovery t\fier Preparative Therapy. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Minor Modification: 4-19-93 
Gansbacher, Berod; Houghton, Alan; and Livingston, Philip, Memorial Sloan Kettering Cancer Center, New York, New York; 
Immunization with HLA-A2 matched Allogeneic Melanoma Cellr that Secrete Interieukin-2 in Patients with Metastatic Melanoma. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Gansbacher, Berod; Motzer, Robert; Houghton, Alan; and Bander, Neil, Memorial Sloan Kettering Cancer Center, New York, New 
York; Immunization with Interieukin-2 Secreting Allogeneic HLA-A2 Matched Renal Cell Carcirtoma Cells in Patients with Advanced 
Renal Cell Carcinonta. 
RAC Approval: 6-2-92/NlH Approval: 8-14-92 
Minor Modification: 3-31-93 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Borte Marrow and 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Multiple Myeloma. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Minor Modification; 1-6-94 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Bone Marrow and 
Peripheral Blood Stem Cells During Autologous Borte Marrow Transplantation for Metastatic Breast Cancer. 
RAC Approval; 6-2-92/NIH Approval: 8-14-92 
Minor Modification: 1-6-94 
Recombinant DNA Research, Volume 19 
L 
